Eosinophilic cellulitislike reaction to subcutaneous etanercept injection

Archives of Dermatology

Volumn 142, Issue 2, 2006, Pages 218-220

  Winfield, Harry ^a   Lain, Edward ^a   Horn, Thomas ^a,b   Hoskyn, Jerri ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIHISTAMINIC AGENT; BENZYL ALCOHOL; ETANERCEPT; HYDROXYCHLOROQUINE SULFATE; MANNITOL; METHOTREXATE; PREDNISONE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLISTER; CASE REPORT; EOSINOPHIL; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; INJECTION SITE REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN EDEMA; SKIN INFILTRATE; SKIN PRURITUS; WELLS SYNDROME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOPSY; CELLULITIS; DIAGNOSIS, DIFFERENTIAL; ECZEMA; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; SKIN;

EID: 33244478316     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.142.2.218     Document Type: Article

References (9)

1. Moossavi M, Mehregan DR. Wells' syndrome: a clinical and histopathologic review of seven cases. Int J Dermatol. 2003;42:62-67.
2. Andreano JM, Kantor GR, Bergfeld WF, Tuthill RJ, Taylor JS. Eosinophilic cellulitis and eosinophilic pustular folliculitis. J Am Acad Dermatol. 1989;20:934-936.
3. Kaufmann D, Pichler W, Beer JH. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Intern Med. 1994;154:1983-1984.
4. Ludwig RJ, Grundmann-Kollmann M, Holtmeier W, et al. Herpes simplex virus type 2-associated eosinophilic cellulitis (Wells' syndrome). J Am Acad Dermatol. 2003;48:S60-S61.
5. Enbrel (etanercept) for subcutaneous injection [package insert]. Thousand Oaks, Calif: Immunex Corporation, Wyeth Pharmaceuticals Inc, and Amgen; 2004.
6. Zeltser R, Valle L, Tanck C, Molyst MM, Ritchlin C, Gaspari AA. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor α receptor: Fc fusion protein. Arch Dermatol. 2001;137:893-899.
7. Murphy FT, Enzenauer RJ. Etanercept-associated injection-site reactions. Arch Dermatol. 2000;136:556-557.
8. Werth VP, Levinson AI. Etanercept-induced injection site reactions: mechanistic insights from clinical findings and immunohistochemistry. Arch Dermatol. 2001;137:953-955.
9. Espana A, Sanz ML, Sola J, Gil P. Well's syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5. Br J Dermatol. 1999;140:127-130.